bisbenzimidazole has been researched along with epirubicin in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bibby, MC; Douglas, KT; Ebrahimi, SE; Fox, KR | 1 |
Bonavida, B; Miki, T; Mizutani, Y; Yoshida, O | 1 |
2 other study(ies) available for bisbenzimidazole and epirubicin
Article | Year |
---|---|
Synthesis, DNA binding, footprinting and in vitro antitumour studies of a meta-hydroxy analogue of Hoechst 33258.
Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; Base Sequence; Benzimidazoles; Binding Sites; Bisbenzimidazole; DNA Adducts; DNA Footprinting; Epirubicin; Humans; Hydroxyl Radical; Molecular Sequence Data; Nucleic Acid Denaturation; Structure-Activity Relationship; Tumor Cells, Cultured | 1995 |
Synergistic cytotoxicity and apoptosis by Apo-2 ligand and adriamycin against bladder cancer cells.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Apoptosis Regulatory Proteins; Bisbenzimidazole; Down-Regulation; Doxorubicin; Drug Synergism; Epirubicin; Fluorescent Dyes; Glutathione S-Transferase pi; Glutathione Transferase; Humans; Isoenzymes; Membrane Glycoproteins; Recombinant Proteins; RNA, Messenger; Staining and Labeling; TNF-Related Apoptosis-Inducing Ligand; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha; Urinary Bladder Neoplasms | 1999 |